Clinical Trial Update: Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

View source ↗

Summary

Update on a completed clinical trial evaluating biomarkers in tumor tissue from patients with Peripheral T-cell lymphoma or natural killer cell neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Natural Killer Cell Neoplasm
• Peripheral T-cell Lymphoma

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Lymphoma | Status: COMPLETED